What: Axios reviews all the (manufactured) abortion pill controversies Marty Makary, the newly confirmed FDA commissioner, will face now that he is leading the agency–including the drama that led to his first pick for a top lawyer at FDA to be scuttled.
Key Line: ‘Makary has already experienced firsthand what a lightning rod mifepristone is shaking out to be. His actions — or inactions — at the beginning of his tenure as FDA commissioner will likely only reinforce that lesson.’
Source: Axios
NBC News highlights fertility statistics showing a 127% increase in birth rates for women over 40.
Study shows over 50% of women don’t receive follow-up after cervical dysplasia treatment.
Studies reinforce that HRT timing may affect Alzheimer’s risk.
KFF survey finds 23% of women reported disrespect from healthcare providers in the past two years.
Dan Weldon, nominee for CDC Director, has a long history of restricting abortion access.
NIH announced winners of a competition focused on endometriosis diagnostics using menstrual blood and specialized imaging.
HHS spokesman Thomas Corry quits after disagreements with Sec. Kennedy and concerns over handling of measles outbreak.
A prenatal test that detects fetal abnormalities has also been shown to identify cancer in pregnant women.
A New York clerk blocked a Texas court filing targeting a doctor who provided abortion pills.
Maternal deaths due to cardiovascular issues more than doubled in the US between 1999 and 2022, with Black women and people in Southern states facing increased risk.
A New York Times analysis of an NBER study found that abortion bans led to higher birth rates, but not an overall increase in fertility.
Texas Republicans propose changes to abortion bans after preventable deaths.
Study highlights barriers preventing women from obtaining permanent contraception after delivery.
Marty Makary faces controversies as the new FDA commissioner.
New federal rules require informing 40 million U.S. women annually about their breast density after mammograms.
A blood test may soon predict postpartum depression before symptoms arise.
Axios investigates gaps in menopause education and training for healthcare providers.
A randomized trial showed virtual education and follow-up via WhatsApp lowered postpartum depression rates.
Carolina Public Press highlights potential solutions to the maternal care crisis in rural areas of North Carolina.
McKinsey examines how AI is poised to revolutionize the beauty industry, from marketing to product development.